cerabone® - Substitut osseux naturel d’origine bovine

cerabone®

Substitut osseux naturel d’origine bovine
La fiabilité et le succès prédictible du traitement font de ce substitut osseux d’origine bovine le matériau de choix pour une majorité des dentistes. cerabone® est caractérisé par une stabilité dimensionnelle élevée, il est par ailleurs hautement fiable et sans risque. Ce matériau issu de la phase minérale de l’os bovin présente une grande similitude avec l’os humain au regard de sa composition chimique, de sa porosité et de sa structure de surface.
  • Préservation de l’alvéole et de la crête
  • Furcations (classes I-II)
  • Augmentation de la crête
  • Défauts péri-implantaires
  • Défauts intra-osseux (1 à 3 parois)
  • Élévation du plancher sinusien

Réhydratation

La réhydratation avec du sang du site du défaut ou dans une solution saline n’est pas nécessaire, mais facilite la manipulation et l’application, les granules humides de cerabone® s’agglutinant ensemble.

Compression des particules

Éviter de comprimer excessivement les particules durant la mise en place ; des particules moins tassées laissent de l’espace pour la croissance des vaisseaux sanguins et la formation d’une nouvelle matrice osseuse.

Période de cicatrisation

Une période de cicatrisation d’au moins 6 mois est recommandée avant la ré-entrée pour garantir une intégration stable des particules.

Mélange du matériau

Le mélange de cerabone® et d’os autologue entraîne une activité biologique (propriétés ostéoinductrices et ostéogéniques de l’os autologue) et favorise une régénération plus rapide et une meilleure formation d’os nouveau.

Regeneration of a 9 mm vertical bone defect with cerabone®, autologous bone and S-PRF –  Dr. A. Eslava

Initial x-ray showing bone loss around implants placed 5 years ago in another dental clinic

cerabone® and mucoderm® for immediacy in esthetic zone -Dr. M Motta

Initial view of the case. Discoloration of 1.1 and mild class I gingival recession

GBR with cerabone® and Jason® membrane in the front tooth region - Dr. H. Maghaireh

Initial clinical situation with gum recession and labial bone loss eight weeks following tooth extraction

botiss cerabone® & Jason® membrane for horizontal augmentation - Clinical case by Dr. M. Steigmann

Three implants placed in a narrow posterior mandible

botiss cerabone® & collprotect® membrane for GBR - Clinical case by Dr. V. Kalenchuk

Clinical situation with narrow alveolar ridge in the lower jaw

Sinus Floor Elevation with maxgraft® bonering and subcrestal implantation in an eggshell thin sinus - Dr. K. Chmielewski

Initial situation: X-ray scan reveals eggshell thin sinus floor (1-3 mm) on both sites of the maxilla; green areas indicate the planned maxgraft® bonerings and red areas the planned implants

Immediate implant placement using cerabone® and collagen fleece - Dr. D. Jelušić

Pre-operative situation showing tooth 21 with deep periodontal pocket. Tooth presented with mobility grade III.

botiss-cerabone-permamem-maxgraft-mucoderm-horizontal-gbr-maghaireh

Initial situation - A young female 34 years old lost her front teeth in an surfing accident and she had a 5 unit bridge supported by her upper left lateral and right canine. The restoration failed and both supporting crowns have exposed and leaking margins.

GBR and soft tissue augmentation with cerabone® and mucoderm® - H. Maghaireh & V. Ivancheva

Initial situation: missing teeth #11 & 12 and badly broken #21 root

botiss cerabone® & Jason® membrane for GBR - Clinical case by Prof. Dr. Dr. D. Rothamel

Instable bridge situation with abscess formation at tooth #15 after apicoectomy

botiss cerabone® & Jason® membrane for GBR - Clinical case by Dr. S. Kovalevsky

Implant insertion in atrophic alveolar ridge

Advanced vertical augmentation in posterior maxilla with maxgraft® bonering - Dr. A. Isser

Initial situation 57-year old female patient. X-ray scan reveals severe bone loss due to inflammation in region 13. Treatment plan was extraction of teeth 13 and 14 and augmentation after healing.

Socket preservation with cerabone® - Dr. P. Kämmerer

Extraction socket grafted with cerabone.

Socket preservation using cerbaone® and permamem® - Dr. A. Caiazzo

Grafting of the extraction socket with small cerabone® granules.

GBR with Jason membrane® and cerabone® - D. Fontana

Lateral view of the defect in the posterior right maxilla.

Sinus lift one-stage with cerabone® and collprotect® membrane - Dr. V. Kalenchuk

Clinical situation of the edentulous distal maxilla before the surgery

botiss cerabone for ridge splitting and augmentation of an atrophic alveolar ridge - Clinical case by Dr. V. Moshirabadi

Situation before augmentation, atrophic alveolar ridge

Block augmentation with maxgraft® and cerabone® – Dr. F. Kloss

Initial CBCT scan - Fracture of left maxillary incisor and loss of buccal wall

Intrabony defect treated using collprotect® membrane & cerabone® (1) - Cosgarea & Sculean

Pre-surgical probing reveals a deep intrabony defect on the distal aspect of the upper canine.

botiss cerabone® & Jason® membrane for block augmentation with autologous bone blocks - clinical case by Dr. S. Stavar

Initial clinical situation with single tooth gap in regio 21

botiss cerabone® & collagen fleece for immediate implantation - Clinical case by Dr. D. Jelušić

Clinical situation before extraction and implantation

botiss cerabone® & Jason® membrane for GBR - clinical case by Dr. S. Stavar

Initial clinical situation with broken bridge abutment in regio 12 and tooth 21 not worth preserving

Restoration of all four incisors with two maxgraft® bonering - Dr. B Giesenhagen

Initial situation pre-op: Central incisors with mobility 3

Block augmentation with maxgraft® in the maxilla - Dr. R. Cutts

Initial situation: 40 year old female patient with extensive scar tissue after several surgeries restored with a Rochette bridge

Ridge augmentation with maxgraft® bonebuilder and sinus floor elevation – Dr. K.P. Schiechl

Initial clinical situation: Bone defect in the upper right maxilla (teeth #14-16)

Horizontal ridge augmentation with maxgraft® cortico - M.Sc. E. Kapogianni

OPG of the initial situation – provision of missing denture in regio 44 to 47 by a resin-retained bridge

Regenerative corticotomy to compensate lower incisor malocclusion with cerabone® and mucoderm®

Initial view of the clinical case: Class III malocclusion
Treatment plan: Regenerative corticotomy (PAOO)

Socket preservation with cerabone® - Dr. Rahib Adi Nader

Situation before extraction with single tooth crowns on 21 and 22

Immediate implant placement and correction of horizontal and vertical bone loss using an allograft bone ring, cerabone® and Jason® membrane - Drs. Miller and Korn

The patient presented with pathologic mobility of upper left central incisor. Radiographic examination revealed significant circumferential attachment loss with an unfavorable crown to root ratio.

Block grafting in the aesthetic zone with maxgraft®, Jason® membrane and cerabone® - Dres. H. Maghaireh and V. Ivancheva

Initial situation – Treatment plan: Replace the adhesive upper left central incisor bridge with a dental implant

Bone augmentation in the aesthetic zone with maxgraft® bonering – Dr. R. Cutts

Initial presentation of failing post retained crown with previous history of failed apicectomies and amalgam tattooing and scar tissue

  • Substitut osseux naturel d’origine bovine
  • Stabilité tridimensionnelle à long terme du greffon
  • Surface rugueuse, adhésion des cellules et absorption du sang optimales
  • Pores interconnectés
  • Sans risque et stérile
  • Manipulation aisée

cerabone® Granules

Article Number

Particle Size

Content

1510

0.5 to 1.0 mm

1 x 0.5 ml

1511

0.5 to 1.0 mm

1 x 1.0 ml

1512

0.5 to 1.0 mm

1 x 2.0 ml

1515

0.5 to 1.0 mm

1 x 5.0 ml

1520

1.0 to 2.0 mm

1 x 0.5 ml

1521

1.0 to 2.0 mm

1 x 1.0 ml

1522

1.0 to 2.0 mm

1 x 2.0 ml

1525

1.0 to 2.0 mm

1 x 5.0 ml

cerabone® Block

Article Number

Dimensions

Content

1720

20 x 20 x 10 mm

1 x Block

Immediate implantation and augmentation by Dr. Derk Siebers
Immediate implantation and augmentation by Dr. Derk Siebers
Lateral sinus lift one-stage by Dr. Derk Siebers
Lateral sinus lift one-stage by Dr. Derk Siebers
Immediate implantation by Dr. Derk Siebers
Immediate implantation by Dr. Derk Siebers
Lateral one-stage sinus lift with cerabone® and Jason® membrane – Dr. Massimo Frosecchi (Italy)
Lateral one-stage sinus lift with cerabone® and Jason® membrane – Dr. Massimo Frosecchi (Italy)
Lateral sinus lift one-stage by Dr. Derk Siebers
Lateral sinus lift one-stage by Dr. Derk Siebers
Socket seal on pig jaw by PD Dr. Dr. D. Rothamel
Socket seal on pig jaw by PD Dr. Dr. D. Rothamel
Augmentation of dehiscence defect by Dr. Marius Steigmann
Augmentation of dehiscence defect by Dr. Marius Steigmann
Immediate tissue augmentation technique with application of cerabone® and Jason® membrane
Immediate tissue augmentation technique with application of cerabone® and Jason® membrane
Ridge preservation by Dr. Derk Siebers
Ridge preservation by Dr. Derk Siebers
Lateral augmentation on pig jaw by PD Dr. Dr. D. Rothamel
Lateral augmentation on pig jaw by PD Dr. Dr. D. Rothamel
GBR with cerabone® and Jason® membrane – Dr. Alfonso Caiazzo (Italy)
GBR with cerabone® and Jason® membrane – Dr. Alfonso Caiazzo (Italy)
cerabone® - natural bovine bone grafting material
cerabone® - excellent biofunctionality - superior hydrophilicity and blood uptake

La forte hydrophilie de la surface de cerabone® permet l’absorption rapide de sang ou de solution saline pour faciliter sa manipulation. De même, son réseau tridimensionnel poreux permet une pénétration et une adsorption rapides des protéines sanguines et sériques, et sert de réservoir de protéines et de facteurs de croissance. Le procédé de fabrication exclusif basé sur une haute température de céramisation supprime tous les composants organiques et élimine toute potentielle réaction immunologique, pour produire un matériau déprotéinisé et sans risque. cerabone® est un substitut osseux naturel d’origine bovine et le matériau préféré d’un grand nombre de dentistes. En 2015, plus de 400.000 patients dans plus de 90 pays avaient déjà été traités avec succès avec cerabone®.

 

[1] Tadic, D. and Epple, M. Biomaterials 2004; Vol. 25 No. 6, pp. 987–994